In a time of increasingly bespoke healthcare, Elizabeth Philp has become a formidable force of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a drive to make bespoke medications more obtainable,